![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.pharmiweb.com/press-release/2024-05-03/resolutions-at-bioinvents-annual-general-meeting-2024
https://www.clinicaltrialsarena.com/news/transgene-and-bioinvent-report-positive-data-for-oncolytic-virus/
https://www.prnewswire.com/news-releases/casi-pharmaceuticals-and-bioinvent-announce-dosing-of-first-patient-in-bi-1206-phase-1-clinical-trial-for-the-treatment-of-relapsedrefractory-non-hodgkins-lymphoma-in-china-301619109.html
https://www.accesswire.com/710367/BioInvent-Enrolls-First-Patient-in-Phase-12a-Trial-of-BI-1607-in-HER2-Positive-Solid-Tumors
https://endpts.com/exelixis-taps-into-cancer-antibody-discoverer-out-of-sweden/
https://www.biospace.com/article/releases/exelixis-and-bioinvent-establish-exclusive-option-and-license-agreement-to-develop-novel-antibody-based-immuno-oncology-therapies/